On the one hand, ALDOB inhibits metastasis through TET1 in hepatocellular carcinoma [28]; on the other hand, it enhances fructose metabolism and drives metabolic reprogramming of colon cancer liver metastasis [29]. Here, ALDOB is linked to malignant colon neoplasm.